Rethinking prompts, reimagining conclusions: Key elements for future large language model-based transfusion medicine education studies
Transfusion Clinique et Biologique · 2026-05 · 33 (2) · 142-143
DOI: 10.1016/j.tracli.2026.02.006 ↗Kurz gefasst
Leserbrief in der Zeitschrift Transfusion Clinique et Biologique, 2026-05. Verfasst von K M Aswin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine and Blood Bank, All India Institute of Medical Sciences, Bibinagar, India. Electronic address: draswinakm@gmail.co…. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Transfusion Medicine and Blood Bank, All India Institute of Medical Sciences, Bibinagar, India. Electronic address: draswinakm@gmail.com.
- Department of Transfusion Medicine and Blood Bank, All India Institute of Medical Sciences, Bibinagar, India. Electronic address: arundr_83@yahoo.co.in.
- Department of Transfusion Medicine and Blood Bank, All India Institute of Medical Sciences, Bibinagar, India. Electronic address: davoodbava@gmail.com.
Zitieren
APA
Aswin, K. M., Arun, R., & Davood, U. B. (2026). Rethinking prompts, reimagining conclusions: Key elements for future large language model-based transfusion medicine education studies. Transfusion Clinique et Biologique, 33(2), 142-143. https://doi.org/10.1016/j.tracli.2026.02.006
Vancouver
Aswin KM, Arun R, Davood UB. Rethinking prompts, reimagining conclusions: Key elements for future large language model-based transfusion medicine education studies. Transfusion Clinique et Biologique. 2026;33(2):142-143. doi:10.1016/j.tracli.2026.02.006
BibTeX
@article{Aswin2026,
author = {Aswin, K M and Arun, R and Davood, U B},
title = {Rethinking prompts, reimagining conclusions: Key elements for future large language model-based transfusion medicine education studies},
journal = {Transfusion Clinique et Biologique},
year = {2026},
volume = {33},
number = {2},
pages = {142--143},
doi = {10.1016/j.tracli.2026.02.006}
}
EUVIMED